Farmasöytisk aerosolformulering av peptider og proteiner, fremgangsmåte forfremstilling av en slik formulering, og anvendelse derav

摘要

A pharmaceutical aerosol formulation comprising (a) a HFA propellant; (b) a pharmaceutically active polypeptide dispersible in the propellant; and (c) a surfactant which is a double-chain phospholipid, which surfactant enhances the systemic absorption of the polypeptide in the lower respiratory tract.